Background: Interposition arthroplasty of the first MTP joint has recently experienced renewed interest as a treatment for hallux rigidus. The purpose of this study was to systematically review the rapidly expanding literature on PRO following interposition arthroplasty of the first MTP joint. Methods: PubMed Central, Embase, and the Cochrane Central Register for Controlled Trials (CENTRAL) were searched. Inclusion criteria included length of time to follow-up, number of patients, outcome measure, and use of allogeneic or autogenous soft tissue or a synthetic matrix as interposition. Results: 20 studies were included in the review, comprising 498 patients and 539 feet with mean time to follow-up of 4.5 years. The most common substance used for interposition in the included studies was autogenous first MTPJ capsular tissue, a technique reported on in 12 (60.0%) of the included articles. In studies reporting preoperative and postoperative outcomes by way of a standardized outcome scoring system, mean group improvements exceed minimal clinically important differences in the majority of studies. Eighty-five percent of the studies included in this review were of Level IV quality evidence, and of this subset of studies, 70.6% were of a retrospective nature. Progression to further surgery was observed in 3.8% of toes. The most common complication reported was transfer metatarsalgia of 1 or more lesser toes, observed in up to 57.9% of patients in one study. Conclusion: Interposition arthroplasty appears to be a viable option for the treatment of moderate to severe hallux rigidus in patients looking to salvage motion through the first metatarsophalangeal joint. A wide array of autogenous, allogeneic, and synthetic implant materials have surfaced in recent years, but long-term follow-up and prospective, comparative study designs with low risk of bias are limited.
Introduction
Hallux rigidus has been treated operatively with a variety of procedures, including fusion, cheilectomy, osteotomy, implant arthroplasty, resection arthroplasty, and interposition arthroplasty. Cheilectomy and first metatarsal/proximal phalangeal osteotomy have a role in operative management of symptomatic early-stage hallux rigidus, whereas arthrodesis and arthroplasty are indicated in the management of more advanced pathology. 37 Despite fusion being the "gold standard" procedure for the treatment of severe hallux valgus, it leads to a limitation of motion through the first metatarsophalangeal joint that is unacceptable to some patients. 40 Silicone, ceramic, and metallic hemi-and total-joint implants have high rates of revision associated with fragmentation, loosening, malalignment, subluxation, and reactive inflammatory and cystic pathology, which makes these implants poor choices in comparison with arthrodesis. 22, 28, 44, 46, 53, 54, 56, 58 In an effort to offer the patient with hallux rigidus an alternative to fusion, various techniques for an "interposition arthroplasty" have been proposed. Interposition arthroplasty is a modification of the Keller resection arthroplasty with the addition of a "spacer," a modification intended to make the procedure a viable option for the more active patient. 24 Despite the description of the successful interposition of dorsal capsule and extensor hallucis brevis in the first MTP joint space for the treatment of advanced hallux rigidus, many modifications to this technique have surfaced. 25 There has been burgeoning interest in the role of autogenous and allogeneic soft-tissue biomaterials and synthetic analogs as both spacers and functional cartilaginous substitutes. 3, 18 The purpose of this review was to systematically review the current state of the literature related to patient outcomes after interposition arthroplasty of the first metatarsophalangeal joint in the treatment of hallux rigidus.
Methods

Search Strategy
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement was used in designing the study, and article selection proceeded in accordance with the multitiered system defined by this statement. 42 Articles were derived from a search of 3 databases: PubMed Central, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL). The search strategy (Supplementary Table 1 ) was employed on December 12, 2017. As a result, publications made available online after this date were not included in the review. Two reviewers (B.E., D.C.) completed title review of articles independently. Where there was divergence of opinion on inclusion of an article in the next stage of the screening protocol, the disagreement was resolved by including the article in further review. At the time of full-text review, the references of each article were searched and studies that were not captured by the combined result of the initial database searches were each evaluated for eligibility.
Study Eligibility Criteria and Data Extraction
Prospective and retrospective studies evaluating the role of interposition arthroplasty in the treatment of hallux rigidus were evaluated for inclusion based on a number of predetermined criteria (Figure 1 ). All articles that met the review's inclusion criteria were scrutinized for data points thought to be critical to a systematic presentation of patient outcomes. Data were extracted by 2 reviewers independently, and any discrepancies in extraction were resolved after further discussion. When complications and frequency of need for further surgery on the ipsilateral hallux were not explicitly addressed by a study, this was differentiated from a report of "zero incidence" and instead documented as "not reported" (N/R).
Quality Assessment of Included Studies
Quality assessment of all included studies was performed using the Modified Coleman Methodology Score (MCMS), a comprehensive tool for assessing both nonrandomized and comparative, randomized studies (Supplementary Table  2 ). 1, 9, 13 As a quality assessment tool, it has been reported to be highly reproducible (r¼0.99). 59 Level of evidence was gauged in accordance with the outline provided by the Oxford Center for Evidence Based Medicine. 61 
Statistical Analysis
The majority of studies were heterogeneous and nonrandomized, 1-armed case series. Quantitative analysis could not be performed given the paucity of studies examining interposition arthroplasty in a comparative setting. For multiarmed studies of a comparative nature containing subgroups undergoing one of several treatments for the arthritic first metatarsophalangeal joint, the "interposition arthroplasty" subgroup was treated separately for qualitative analysis. Because of the heterogeneity of studies with respect to operative procedure, patient population, and outcome measure, meta-analysis was not possible.
Results
Study Inclusion
Five hundred eighty articles were pulled from the combined database search, of which 172 appeared in more than 1 database. A total of 408 distinct articles were subject to title review. Articles were selected according to a well defined screening procedure ( Figure 2 ). Ultimately, 20 studies were included (Table 1) .
Study Quality Assessment and Levels of Evidence
The average MCMS for the included studies was 49.7+9.2 (range, 33-63) indicating subpar methodological quality of the available literature ( Table 2) . Of the 17 studies of Level IV quality evidence, 12 (70.6%) defined their study populations retrospectively and/or collated and analyzed outcome scores based on a retrospective review of patient medical records. Of the 3 Level III studies, 2 concluded that interposition arthroplasty affords equivalent clinical outcomes to alternative surgical treatments (arthrodesis and Keller resection arthroplasty) and 1 reported inferior outcomes in the setting of comparison with cheilectomy ( Table 3) . 34, 36, 51 
Demographic Characteristics of Included Study Populations
A total of 498 patients and 539 feet underwent interposition arthroplasty of the first metatarsophalangeal joint with placement of an allogeneic, autogenous, or synthetic matrix as a joint spacer. The average age of the patients reported on was 57.6. Average time to follow-up for all patients was 4.5 years, with the average time to follow-up for included studies spanning the range of 1.4 to 11.3 years (Table 1) .
Interposition arthroplasty was performed as an operative intervention most commonly in a patient population with advanced degenerative changes at the first metatarsophalangeal joint. Thirteen (65.0%) studies described their study groups by way of the comprehensive Coughlin and Shurnas classification for grading first MTP joint damage. 8, 32 Operative intervention was most common in a population with grade 3 to 4 joint damage. The less comprehensive Hattrup and Johnson and Roukis classification systems were used less commonly, with grade 3 hallux rigidus patients, according to each respective classification system, the most common candidates for interposition arthroplasty. 26, 47 Complications were expressed as counts as opposed to percentages of a study population, as when manuscripts reported multiple types of complications, often these were not specified as occurring in discrete vs overlapping patients. b Complication counts are relatively high for some studies, probably because of inequivalence across studies as to what constituted a complication (ie, Ozan et al deem "loss of ground contact of the big toe" a complication).
In the 10 studies that reported on history of prior surgery on the ipsilateral hallux, 5 studies had some portion of the treatment group undergoing interposition arthroplasty as a revision procedure at the hallux. Prior surgeries included failed Keller resection arthroplasty, total toe replacement, phalangeal resurfacing implant, Chevron osteotomy, plantarflexion osteotomy, bursectomy, cheilectomy, dorsal osteophyte excision, and an interphalangeal fusion.
Interposition Material and Metatarsophalangeal Joint Decompression
The most common substance used for interposition in the included studies was autogenous first MTPJ capsular tissue with or without the extensor halluces brevis tendon, a technique reported on in 12 (60.0%) of the included articles (Table 1 ). There was some variability in the technique used for interposing autogenous capsular tissue. While a proximally based, dorsal capsule was most commonly used, 2 studies described interposition of a distally based capsule and 1 study reported interposition of medial capsular tissue sutured to the lateral capsule. 23, 48, 60 The remaining studies reported interposition of a number of allogeneic and autogenous soft tissue types and synthetic matrices (Table 1) . 2, 15, 16, 17, 20, 21, 27, 29, 55 After 2010, a trend was noted toward increased usage of interpositional substances other than autogenous first MTPJ capsule (61.5% of studies after 2010 vs 7.7% of studies up through 2010).
Of the 12 included studies describing autogenous first MTPJ capsular interposition, 3 (25.0%) studies explicitly defined the proximal phalangeal resection procedure as 25% of the bony substance with concomitant removal of intrinsic plantar attachments. 34, 45, 51 The remaining studies describe less extensive proximal phalangeal excision with explicit mention of preservation of plantar attachments. Significant variability was noted in description of decompressive procedures of the metatarsal head, with resection ranging from isolated anatomic recontouring to "aggressive" dorsal cheilectomy.
Complications and Reoperation
The most common complication reported was transfer metatarsalgia of 1 or more lesser toes, with the range of incidence from 0.0% to 57.9%. Less frequent complications reported included calluses under the lesser metatarsal heads (27.3%-42.8%), 15, 34 stress fracture of one of the lesser toes resulting from transfer metatarsalgia (4.8%-9.1%), 10, 21, 23, 31, 34 sensory neuroma or hyperpigmentation at the site of autograft harvesting (6.7%-14.3%), 15, 21 radiographic evidence of osteonecrosis of the first metatarsal head (7.7%-40.8%), 10,51 numbness at the dorsum of the hallux or generalized hypoesthesia of the hallux (9.1%-15.8%), 10,45,51 infection with or without need for subsequent debridement (1.5%-6.7%), 2,20,21 cock-up deformity (4.5%), 2 proximal phalangeal cystic development (8.7%), 16 claw-toe deformity (5.6%), 20 extensor hallucis longus (EHL) tendon entrapment (3.1%), 27 capsular ossification (4.5%), 51 and regional pain syndrome (4.5%). 51 In the 14 studies explicitly describing need for further surgery on the ipsilateral first MTPJ, 15 (3.8%) toes progressed to a subsequent operation. These further operations included arthrodesis (range of progression frequency, 2.3%-9.5%), 2, 16, 20, 27, 60 revision interposition arthroplasty (0.75%), 2 manipulation under anesthesia to improve range of motion (4.8%), 31 debridement of the joint with EHL tenolysis (0.75%), 2 and debulking of an oversized graft and further proximal phalangeal resection (6.7%). 21 
Standardized and Subjective Outcome Measures
The most commonly used outcome scoring measure was the American Orthopaedic Foot & Ankle Society Hallux Metatarsophalangeal-Interphalangeal Scoring System (AOFAS-HMI). Two (10.0%) studies used a modified, reweighted version of the scale (Table 4 ). 29, 48 The minimal clinically important difference (MCID) for the AOFAS-HMI total score has only been studied in the setting of hallux valgus corrective surgery but is reported with some uncertainty, spanning the range of 7.9 to 30.2. 11 Of the 8 studies reporting preoperative and postoperative scores by way of an unmodified AOFAS-HMI scale, 6 (75.0%) reported mean improvement in the AOFAS-HMI total score exceeding 30.2 points, with the 2 additional studies reporting mean improvements of 23.0 and 24.6, respectively. 10, 15, 17, 20, 27, 45, 51, 55 The validated Foot Function Index (FFI), Foot and Ankle Ability Measure (FAAM), the Visual Analog Scale for Pain (Pain VAS), and the Short Form-36 Health Survey (SF-36) were the next most commonly used standardized outcome scoring measures. Of the 4 studies reporting pre and postoperative scores by one of these measures, all reported mean improvements exceeding the MCIDs for their respective scoring systems (MCIDs: FAAM-ADL, 8; FAAM-Sports,  9 ; Pain VAS, 30% difference; FFI-Total, 7). 33, 35, 39 Ten (50%) studies reported both preoperative and postoperative range of motion measurements with statistical treatment of the observed changes in range of motion. Nine (90.0%) of these studies reported statistically significant improvements in dorsiflexion from preoperation to postoperation whereas the 2 studies quantifying change in plantarflexion noted no improvements in this measure. A wide variety of additional subjective outcomes were collected across the included studies in an effort to measure patient satisfaction and level of function (Table 4 ).
Discussion
Interposition arthroplasty appears to be a viable option for the treatment of moderate to severe hallux rigidus in a patient population looking to salvage motion through the first metatarsophalangeal joint. In studies reporting preoperative and postoperative outcomes with an outcome scoring system, mean group improvements exceed MCIDs in the majority of studies. Subjective patient-reported outcomes suggest a high percentage of postoperative satisfaction, and improved postoperative range of motion in dorsiflexion is frequently noted.
Nonetheless, these findings should be interpreted with caution. The large majority (85.0%) of the studies included in this review were of Level IV quality evidence, and of this subset of studies, 70.6% were of a retrospective nature. Only 14 (70.0%) of the included studies captured both preoperative and postoperative scoring measures on their treatment groups. Using a retrospective chart review to collate AOFAS-HMI scores is a practice that has been subject to criticism in the past, given its tendency to underestimate the tabulated value and subsequently inflate the impression of a treatment's efficacy. 52 There is conflicting evidence in the literature as to the true construct validity and reliability of the AOFAS scoring system, and its historically central place as a proxy for surgical outcome from treatment of the hallux has been questioned. 5, 30, 38, 57 Additionally, in the comparative setting with arthrodesis, the AOFAS scoring system is a limited construct, given its partial assessment of outcome as a function of mobility.
Currently, there is significant interest in defining the relative efficacy of first metatarsophalangeal joint fusion in comparison to a motion-salvaging, interpositional technique. Only 1 study included in this review offered such a comparison: a Level III retrospective study concluding that interposition of autogenous dorsal capsule affords a more normal pattern of plantar pressure during standard gait than does arthrodesis with equivalent clinical outcomes. 36 However, use of the AOFAS-HMI as a scoring system, the retrospective character of the study, and underpowered sample sizes for cross-treatment comparisons all limit the study's conclusions. More recently, a prospective, randomized, noninferiority trial was conducted to assess the efficacy of polyvinyl alcohol hydrogel implant in the setting of a sideby-side comparison with arthrodesis. 6 The investigation concluded that the implant is safe and affords equivalent functional outcomes and pain relief as does arthrodesis through short-term follow-up. As a prospective randomized trial with a prospectively defined endpoint, use of validated outcome scoring measures, high rate of follow-up, a standardized surgical procedure, and a multicentered and geographically inclusive design, the study in many ways has set a gold standard for how surgical options for hallux rigidus might be evaluated moving forward. A subset of the hydrogel implant group has now reached minimum 5-year followup, and, as noted in this review, the implant has demonstrated high rates of survival (96.3%) at midterm. 16 Nevertheless, whether these success rates will be reproduced in studies born from third-party investigators is unknown and such studies will be received with great interest.
Beyond the above-mentioned prospective, randomized study, only 2 additional studies included in this review reported outcomes based on the grade of degenerative change at the first MTP joint. One study reported significant improvement (P < .01) in patients with grade 3 over grade 4 hallux rigidus (Coughlin and Shurnas Classification). 50 However, the clinical significance of the differences in those postoperative outcome scores is unclear. Radiographic grade was found to make no difference with regard to outcome in another study. 31 Although patient selection is thought to be important in optimizing surgical outcome, the mainstay classification schemes for grading hallux rigidus severity do not appear to correlate with intraoperative findings, pain, and active range of motion. 7 Future studies exploring the role of interposition arthroplasty and arthrodesis in a comparative setting might benefit from exploring outcome as a function of intraoperative appearance of the joint, preoperative pain levels, and range of motion rather than by levels of the existing classifications for grading joint deterioration. The difficulty with a randomized assignment of interposition arthroplasty and arthrodesis is the strong preferences patients may hold to maintain postoperative motion through the hallux. As randomization can lead to a significant rate of study dropout (23.0%), high-quality, nonrandomized, prospective cohort studies might be a more feasible option for exploring this comparison. 6 The resection arthroplasty with subsequent interposition of autogenous soft tissue has long been described, even prior to the dates of publication of the studies included in this review. Both "bundle soft tissue" interposition arthroplasty and capsular interposition techniques have a long history in the literature, with very early descriptions of this "bundle soft tissue" technique including interposition of gastrocnemius-soleus tendon, extensor halluces longus tendon, gracilis tendon, and plantaris tendon bundles. 4, 14, 41 However, the most recent systematic review dedicated to exploring outcomes from these interpositional techniques pre-dated the rapid emergence of outcome-centered investigations exploring the role of allogeneic soft tissue and synthetic, pliable substrates as joint spacers. 49 Many of these studies have surfaced in the literature in recent years, as the movement toward both promoting chondrostimulation and regeneration and developing matrices to serve as functional chondral replacement has gained momentum. [18] [19] [20] [21] 27, 29, 55 Interestingly, studies reporting on opportunities for biopsy of autogenous interposed capsular tissue in the setting of surgery needed on the lesser rays after interposition arthroplasty have noted the appearance of a viable fibrocartilaginous flap in the first MTP joint. 2, 43 Despite all of these innovative and promising efforts, only 1 of the studies included in this review evaluated autogenous and allogeneic interpositional material comparatively, noting no difference in failure rate or incidence of transfer metatarsalgia between the placement of autogenous dorsal capsule and acellular dermal matrix allograft. 2 Immunogenic reactions have been reported anecdotally with allografting of the first MTP joint, whereas autogenous "bundle soft tissue" placement has been associated with donor site morbidity. 15, 21 Although the isolated dorsal and medial autogenous capsular interpositional techniques can minimize these potential complications, the local capsular interpositional techniques may not provide sufficient tissue for grafting, particularly of the sesamoid-metatarsal articulation. Additionally, although the technique has evolved over time to minimize the extent of phalangeal resection and to preserve plantar proximal phalangeal attachments, transfer metatarsalgia is still observed with some frequency as a postoperative complication. At this time, despite an array of available interpositional materials, there is limited evidence suggesting the improved efficacy of one implant over the many others. The relative importance of the quality and extent of debridement and decompressive technical work vs graft choice also remains unclear.
There are a number of limitations of this review, primarily related to the quality of the current literature that is available on this subject, which in many ways is an important finding in and of itself. The paucity of prospective, multiarmed studies using a reliable and validated common scoring measure prevented the possibility of meta-analyses and firm treatment recommendations. Additionally, the generalizability and sustainability of the included studies' findings are difficult to gauge, given that the treatment populations were fewer than 30 patients in 75% of the included studies and 70% of the studies evaluated patients at less than midterm follow-up time.
In conclusion, interposition arthroplasty appears to be a viable option for the treatment of moderate to severe hallux rigidus in patients looking to salvage motion through the first metatarsophalangeal joint. A wide array of autogenous, allogeneic, and synthetic implants have debuted in recent years, but long-term follow-up and prospective, comparative studies are lacking. Patient-reported outcomes suggest high postoperative satisfaction, and improved postoperative range of motion in dorsiflexion is frequently noted regardless of interpositional material and operative technique.
